Healthcare >> CEO Interviews >> March 3, 2000
TOD R. HAMACHEK was named Chairman and CEO of Penwest
Pharmaceuticals Co. in October 1997. Prior to the spinoff of
Penwest Pharmaceuticals from Penford Corporation, Ltd., he was
President and CEO of Penford. Previously, he was Senior Vice
President of the manufacturing group of Univar Corporation,
Penwest's parent at that time. Penwest was spun off from Univar
in 1984. From 1979 to 1984 he was President and CEO of Great
Western Malting Co., a Univar subsidiary, where he also served as
Vice President, Sales and Assistant to the President. He began
his professional career in 1970 at the Harris Corporation,
Westerly, Rhode Island, and was National Sales Manager when he
left to join Great Western in 1974. Mr. Hamachek earned his BA
degree at Williams College and his MBA from the Harvard Business
School. He is a member of the Boards of Directors of Northwest
Natural Gas Company, The Seattle Times Co. and the Blethen
Corporation (the majority owner of The Seattle Times). He is a
Trustee of Williams College and The National Peace Garden
Foundation. He is past Director of First Interstate Bank of
Washington and DEKALB Genetics Corporation; past Trustee of Lewis
& Clark College, the Nature Conservancy ' Washington Chapter,
Pacific Science Center, and the Pacific Northwest Arts and Crafts
Association; past Chairman of the Board of Trustees of The
Pacific Crest Outward Bound School; and past Trustee of Outward
Bound, Inc. Mr. Hamachek is married and resides in Connecticut. Profile
Pharmaceuticals?
Mr. Hamachek: Penwest Pharmaceuticals was created in 1998 as a spin-off
from the Penford Corporation. Penford is
